These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37419404)
61. Specificity and impact of adrenergic projections to the midbrain dopamine system. Mejias-Aponte CA Brain Res; 2016 Jun; 1641(Pt B):258-73. PubMed ID: 26820641 [TBL] [Abstract][Full Text] [Related]
62. Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake. Jensen KL; Runegaard AH; Weikop P; Gether U; Rickhag M J Vis Exp; 2017 Sep; (127):. PubMed ID: 28994779 [TBL] [Abstract][Full Text] [Related]
63. Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization. Wang H; Kim SS; Zhuo M J Biol Chem; 2010 Jul; 285(28):21888-901. PubMed ID: 20457613 [TBL] [Abstract][Full Text] [Related]
64. Coordinated Postnatal Maturation of Striatal Cholinergic Interneurons and Dopamine Release Dynamics in Mice. McGuirt AF; Post MR; Pigulevskiy I; Sulzer D; Lieberman OJ J Neurosci; 2021 Apr; 41(16):3597-3609. PubMed ID: 33664134 [TBL] [Abstract][Full Text] [Related]
65. L-cysteine capped ZnS:Mn quantum dots for room-temperature detection of dopamine with high sensitivity and selectivity. Diaz-Diestra D; Thapa B; Beltran-Huarac J; Weiner BR; Morell G Biosens Bioelectron; 2017 Jan; 87():693-700. PubMed ID: 27631684 [TBL] [Abstract][Full Text] [Related]
66. Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography. Finnema SJ; Bang-Andersen B; Wikström HV; Halldin C Curr Top Med Chem; 2010; 10(15):1477-98. PubMed ID: 20583987 [TBL] [Abstract][Full Text] [Related]
67. Photoactivatable Dopamine and Sulpiride to Explore the Function of Dopaminergic Neurons and Circuits. Asad N; McLain DE; Condon AF; Gore S; Hampton SE; Vijay S; Williams JT; Dore TM ACS Chem Neurosci; 2020 Mar; 11(6):939-951. PubMed ID: 32077679 [TBL] [Abstract][Full Text] [Related]
68. Detection of neuropeptides in vivo and open questions for current and upcoming fluorescent sensors for neuropeptides. Inutsuka A; Ino D; Onaka T Peptides; 2021 Feb; 136():170456. PubMed ID: 33245950 [TBL] [Abstract][Full Text] [Related]
69. Establishing causality for dopamine in neural function and behavior with optogenetics. Steinberg EE; Janak PH Brain Res; 2013 May; 1511():46-64. PubMed ID: 23031636 [TBL] [Abstract][Full Text] [Related]
70. Dopaminergic regulation of the GT1 gonadotropin-releasing hormone (GnRH) neuronal cell lines: stimulation of GnRH release via D1-receptors positively coupled to adenylate cyclase. Martínez de la Escalera G; Gallo F; Choi AL; Weiner RI Endocrinology; 1992 Dec; 131(6):2965-71. PubMed ID: 1280208 [TBL] [Abstract][Full Text] [Related]
71. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol. Garris PA; Budygin EA; Phillips PE; Venton BJ; Robinson DL; Bergstrom BP; Rebec GV; Wightman RM Neuroscience; 2003; 118(3):819-29. PubMed ID: 12710989 [TBL] [Abstract][Full Text] [Related]
72. Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation. Saddoris MP; Cacciapaglia F; Wightman RM; Carelli RM J Neurosci; 2015 Aug; 35(33):11572-82. PubMed ID: 26290234 [TBL] [Abstract][Full Text] [Related]
74. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum. Wei W; Ding S; Zhou FM J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785 [TBL] [Abstract][Full Text] [Related]
75. Imaging Neurotransmitter and Neuromodulator Dynamics In Vivo with Genetically Encoded Indicators. Sabatini BL; Tian L Neuron; 2020 Oct; 108(1):17-32. PubMed ID: 33058762 [TBL] [Abstract][Full Text] [Related]
76. Understanding the role of dopamine in cancer: past, present and future. Grant CE; Flis AL; Ryan BM Carcinogenesis; 2022 Jun; 43(6):517-527. PubMed ID: 35616105 [TBL] [Abstract][Full Text] [Related]
77. Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: mechanism and kinetics. Pham AN; Waite TD J Inorg Biochem; 2014 Aug; 137():74-84. PubMed ID: 24815905 [TBL] [Abstract][Full Text] [Related]
78. Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease. Chen APF; Chen L; Kim TA; Xiong Q Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34200134 [TBL] [Abstract][Full Text] [Related]
79. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506 [TBL] [Abstract][Full Text] [Related]
80. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain. Yamamoto Y; Takahata K; Kubota M; Takano H; Takeuchi H; Kimura Y; Sano Y; Kurose S; Ito H; Mimura M; Higuchi M Neuroimage; 2021 Feb; 226():117543. PubMed ID: 33186713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]